학술논문
A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445